The Renton, Washington-based health system said inflation, labor shortages, delayed reimbursement from payers and supply chain problems are still affecting its bottom line, but its financial outlook is improving.
Providence narrowed losses as patient volumes increased Read More »
Those grantees on average are reimbursed almost four times more for 340B prescription drugs than what they pay, and make billions in 340B drug margin, according to the report, which was funded by Gilead Sciences.
Check out BioSpace’s guide to pharma tech jobs, complete with job descriptions and average salaries.
The Salt Lake City-based health system reported net income of $549 million, after a loss in the first three months of 2022.
Intermountain posts profit after revenue grew in Q1 Read More »
Ex-FDA Neuroscience Director Billy Dunn was appointed to Prothena’s board of directors last week. Industry representatives and regulatory experts weigh in on the potential ethical implications.
Billy Dunn’s Prothena Board Position Reignites Ethical Debate Read More »
Hip growth should normalize late this year, while the knee and spine markets are expected to slow down by the end of 2024, say analysts at Needham.
Orthopedic markets to return to normal this year as post-pandemic boost fades: analysts Read More »
Los resultados de un estudio reciente ofrecen una alternativa más económica y sostenible para la construcción con marcos prefabricados de hormigón de infraestructuras de transporte, como túneles subterráneos y otras estructuras. El estudio lo han re …
Algoritmos para una construcción más limpia y más barata de túneles subterráneos Read More »
Las especies carnívoras con tamaño corporal mediano (mesodepredadores como coyotes o linces) tienden a trasladarse a áreas dominadas por humanos para evitar la depredación por carnívoros de mayor tamaño, un fenómeno también conocido como el efe …
El lado oscuro del efecto escudo humano en animales que evitan a depredadores mayores Read More »
Protalix BioTherapeutics, Inc. announced that it is set to join the broad-market Russell 3000® Index at the conclusion of the 2023 Russell indexes annual reconstitution, effective after the US market opens on June 26, 2023 according to a preliminary list of additions posted May 19.
Protalix BioTherapeutics set to join Russell 3000® Index Read More »
La computación cuántica actual presenta un gran reto: demostrar un ordenador cuántico tolerante a los fallos (la llamada decoherencia cuántica). Para ello, una de las posibles soluciones es la corrección de errores, mediante un escalado masivo que necesita, al meno …
Logran un bit cuántico semiconductor en un circuito superconductor Read More »
